hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.
about
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
hERG1 behaves as biomarker of ...... novel endoscopic surveillance.
@en
hERG1 behaves as biomarker of ...... novel endoscopic surveillance.
@nl
type
label
hERG1 behaves as biomarker of ...... novel endoscopic surveillance.
@en
hERG1 behaves as biomarker of ...... novel endoscopic surveillance.
@nl
prefLabel
hERG1 behaves as biomarker of ...... novel endoscopic surveillance.
@en
hERG1 behaves as biomarker of ...... novel endoscopic surveillance.
@nl
P2093
P2860
P356
P1433
P1476
hERG1 behaves as biomarker of ...... novel endoscopic surveillance.
@en
P2093
Anna Tomezzoli
Annarosa Arcangeli
Bruno Compagnoni
Carla Vindigni
Claudia Duranti
Elena Lastraioli
Giancarlo Freschi
Giovanni De Manzoni
Ilaria Manzi
Jessica Iorio
P2860
P304
59535-59547
P356
10.18632/ONCOTARGET.11149
P407
P577
2016-08-09T00:00:00Z